Photo from wikipedia
Results from the second CONCORD study (CONCORD‐2) indicated that 5‐year net survival for lung cancer was low (range, 10%‐20%) between 1995 and 2009 in most countries, including the United States,… Click to show full abstract
Results from the second CONCORD study (CONCORD‐2) indicated that 5‐year net survival for lung cancer was low (range, 10%‐20%) between 1995 and 2009 in most countries, including the United States, which was at the higher end of this range.
Keywords:
concord study;
united states;
lung cancer;
cancer;
concord
Journal Title: Cancer
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!